These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27712845)

  • 1. Pharmacogenetic Optimization of Smoking Cessation Treatment.
    Chenoweth MJ; Tyndale RF
    Trends Pharmacol Sci; 2017 Jan; 38(1):55-66. PubMed ID: 27712845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations.
    Claw KG; Beans JA; Lee SB; Avey JP; Stapleton PA; Scherer SE; El-Boraie A; Tyndale RF; Nickerson DA; Dillard DA; Thummel KE; Robinson RF
    Nicotine Tob Res; 2020 May; 22(6):910-918. PubMed ID: 31241144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
    Chen LS; Bloom AJ; Baker TB; Smith SS; Piper ME; Martinez M; Saccone N; Hatsukami D; Goate A; Bierut L
    Addiction; 2014 Jan; 109(1):128-137. PubMed ID: 24033696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation.
    Salloum NC; Buchalter ELF; Chanani S; Espejo G; Ismail MS; Laine RO; Nageeb M; Srivastava AB; Trapp N; Trillo L; Vance E; Wenzinger M; Hartz SM; David SP; Chen LS
    Pharmacogenomics; 2018 Jul; 19(10):861-871. PubMed ID: 29914292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.
    Lee AM; Tyndale RF
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):7-14. PubMed ID: 16785264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNPs within CHRNA5-A3-B4 and CYP2A6/B6, nicotine metabolite concentrations and nicotine dependence treatment success in smokers.
    Hubacek JA; Kurcova I; Maresova V; Pankova A; Stepankova L; Zvolska K; Lanska V; Kralikova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Mar; 165(1):84-89. PubMed ID: 31796940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism.
    Perez-Paramo YX; Lazarus P
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):333-349. PubMed ID: 33322962
    [No Abstract]   [Full Text] [Related]  

  • 9. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.
    Ray R; Tyndale RF; Lerman C
    J Neurogenet; 2009; 23(3):252-61. PubMed ID: 19169923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine Metabolism Predicted by CYP2A6 Genotypes in Relation to Smoking Cessation: A Systematic Review.
    Jones SK; Wolf BJ; Froeliger B; Wallace K; Carpenter MJ; Alberg AJ
    Nicotine Tob Res; 2022 Mar; 24(5):633-642. PubMed ID: 34478556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of nicotine and associated smoking behaviors.
    Tanner JA; Chenoweth MJ; Tyndale RF
    Curr Top Behav Neurosci; 2015; 23():37-86. PubMed ID: 25655887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme.
    Bray MJ; Chen LS; Fox L; Hancock DB; Culverhouse RC; Hartz SM; Johnson EO; Liu M; McKay JD; Saccone NL; Hokanson JE; Vrieze SI; Tyndale RF; Baker TB; Bierut LJ
    Genet Epidemiol; 2020 Oct; 44(7):748-758. PubMed ID: 32803792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of CYP2A6 Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success.
    Chenoweth MJ; Lerman C; Knight J; Tyndale RF
    Nicotine Tob Res; 2023 May; 25(6):1207-1211. PubMed ID: 36789481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
    Bergen AW; Michel M; Nishita D; Krasnow R; Javitz HS; Conneely KN; Lessov-Schlaggar CN; Hops H; Zhu AZ; Baurley JW; McClure JB; Hall SM; Baker TB; Conti DV; Benowitz NL; Lerman C; Tyndale RF; Swan GE;
    PLoS One; 2015; 10(7):e0126113. PubMed ID: 26132489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
    Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
    Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Benowitz NL
    Clin Pharmacol Ther; 2008 Apr; 83(4):531-41. PubMed ID: 18305452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco addiction and pharmacogenetics of nicotine metabolism.
    Swan GE; Lessov-Schlaggar CN
    J Neurogenet; 2009; 23(3):262-71. PubMed ID: 19152209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
    Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
    Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on Chen et al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation?
    David SP
    Addiction; 2014 Jan; 109(1):138-9. PubMed ID: 24438115
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.
    Ohmoto M; Takahashi T; Kubota Y; Kobayashi S; Mitsumoto Y
    BMC Genet; 2014 Dec; 15():151. PubMed ID: 25526961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.